Association Between Blood Glucose and Long-Term Mortality in Patients With Acute Coronary Syndromes in the OPUS-TIMI 16 Trial

American Journal of Cardiology

Volumn 97, Issue 11, 2006, Pages 1573-1577

  Bhadriraju, Satish ^b   Ray, Kausik K ^a   DeFranco, Anthony C ^b   Barber, Kim ^b   Bhadriraju, Padmini ^b   Murphy, Sabina A ^a   Morrow, David A ^a   McCabe, Carolyn H ^a   Gibson, C Michael ^a   Cannon, Christopher P ^a   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; ORBOFIBAN; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POST HOC ANALYSIS; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 33646694589     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.12.046     Document Type: Article

References (18)

1. Colwell J.A. Vascular thrombosis in type II diabetes mellitus. Diabetes 42 (1993) 8-11
2. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes. a systematic overview. Lancet 355 (2000) 773-778
3. Yudkin J.S., and Oswald G.A. Hyperglycaemia, diabetes and myocardial infarction. Diabet Med 4 (1987) 13-18
4. Fava S., Aquilina O., Azzopardi J., Agius Muscat H., and Fenech F.F. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabet Med 13 (1996) 80-83
5. Oswald G.A., Smith C.C., Betteridge D.J., and Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 293 (1986) 917-922
6. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., and Krumholz H.M. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
7. Svensson A.M., McGuire D.K., Abrahamsson P., and Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26 (2005) 1255-1261
8. Cannon C.P., McCabe C.H., Wilcox R.G., Langer A., Caspi A., Berink P., Lopez-Sendon J., Toman J., Charlesworth A., Anders R.J., et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 102 (2000) 149-156
9. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
10. Pinto D.S., Skolnick A.H., Kirtane A.J., Murphy S.A., Barron H.V., Giugliano R.P., Cannon C.P., Braunwald E., and Gibson C.M. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 46 (2005) 178-180
11. Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., and Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus. a prospective study. Lancet 359 (2002) 2140-2144
12. Foo K., Cooper J., Deaner A., Knight C., Suliman A., Ranjadayalan K., and Timmis A.D. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
13. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
14. Sadanandan S., Cannon C.P., Chekuri K., Murphy S.A., Dibattiste P.M., Morrow D.A., de Lemos J.A., Braunwald E., and Gibson C.M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
15. Verma S., Wang C.H., Weisel R.D., Badiwala M.V., Li S.H., Fedak P.W., Li R.K., and Mickle D.A. Hyperglycemia potentiates the proatherogenic effects of C-reactive protein. reversal with rosiglitazone. J Mol Cell Cardiol 35 (2003) 417-419
16. Gresele P., Guglielmini G., De Angelis M., Ciferri S., Ciofetta M., Falcinelli E., Lalli C., Ciabattoni G., Davi G., and Bolli G.B. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 41 (2003) 1013-1020
17. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., Suryapranata H., Zijlstra F., and van't Hof A.W. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 999-1002
18. Mjos O.D. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 50 (1971) 1386-1389